Clinical evaluation on fengweicao granule in treating benign prostatic hyperplasia.
- Author:
Bo-Xin XUE
1
;
Yu-Xi SHAN
;
Gui XIANG
Author Information
- Publication Type:Journal Article
- MeSH: Diuresis; drug effects; Drugs, Chinese Herbal; therapeutic use; Enzyme Inhibitors; therapeutic use; Finasteride; therapeutic use; Humans; Male; Medicine, Chinese Traditional; Prostatic Hyperplasia; drug therapy; Pteris
- From: Chinese Journal of Integrated Traditional and Western Medicine 2008;28(5):456-458
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo report the effect of Fengweicao Granule (FWCCG), a Chinese herbal preparation made of herba Pteris multifidae, in treating benign prostatic hyperplasia (BPH).
METHODSOne hundred and fifty-five patients were assigned to two groups, the 108 patients in the treated group were administered orally with FWCG twice a day, 5 g every time; the 47 patients in the control group were treated with Proscar 5 mg per day for 3 months. The effects were evaluated by the change of the related indexes before and after treatment, including scoring by international prostatic symptom scale (I-PSS), maximum flowing rate of urine (MFR), residue urine volume (RU) in urinary bladder determined by abdominal B-ultrasonography and volume of prostate.
RESULTSAfter being treated for 3 months, the I-PSS, MFR and RU improved remarkably in both groups (P <0.05 or P <0.01), but with no significant change in the volume of prostate, neither with significant difference in comparison between the two groups (P >0.05).
CONCLUSIONFWCG has a good effect with less adverse reaction in treating BPH.
